Max Healthcare Institute Ltd
Max Healthcare Institute Ltd (MAXHEALTH) last reported results for the quarter ended Jun 2026, with sales of ₹2,366 crore and net profit of ₹323 crore. The next scheduled event is a corporate event on 22 Oct 2026. The stock last traded at ₹904, a market capitalisation of ₹87,968 crore, on a P/E of 58.8. Over the past 52 weeks the stock has ranged between ₹895 and ₹1,222. Figures are as of 6 Oct 2026 and are not real time.
Max Healthcare Institute Ltd share price and key metrics
- Current price
- ₹904
- Market cap
- ₹87,968 cr
- Stock P/E
- 58.8
- Book value
- ₹110
- ROE
- 14.7%
- ROCE
- 14.7%
- Dividend yield
- 0.22%
- 52w high / low
- 1222/895
Metrics as of 6 Oct 2026. Not real time.
Track Max Healthcare Institute Ltd
Cruxal reads every Max Healthcare Institute Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Max Healthcare Institute Ltd growth and returns
- 10 Years
- %
- 5 Years
- 27%
- 3 Years
- 22%
- TTM
- 16%
- 10 Years
- %
- 5 Years
- 60%
- 3 Years
- 10%
- TTM
- 25%
- 10 Years
- %
- 5 Years
- 21%
- 3 Years
- 18%
- 1 Year
- -20%
- 10 Years
- 11%
- 5 Years
- 14%
- 3 Years
- 14%
- Last Year
- 15%
Max Healthcare Institute Ltd quarterly results
In the quarter ended Jun 2026, sales were ₹2,366 cr, up 16.7% from ₹2,028 cr a year earlier. Net profit was ₹323 cr, up 4.9% year on year.
| ₹ crore | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 1,707 | 1,868 | 1,910 | 2,028 | 2,135 | 2,068 | 2,143 | 2,366 |
| Expenses | 1,257 | 1,369 | 1,398 | 1,505 | 1,560 | 1,529 | 1,536 | 1,768 |
| Operating profit | 451 | 499 | 512 | 523 | 575 | 538 | 606 | 598 |
| OPM % | 26% | 27% | 27% | 26% | 27% | 26% | 28% | 25% |
| Other income | 41 | -40 | 47 | 37 | 33 | -3 | 48 | 41 |
| Interest | 34 | 52 | 55 | 55 | 54 | 60 | 67 | 71 |
| Depreciation | 84 | 98 | 101 | 104 | 108 | 111 | 123 | 132 |
| Profit before tax | 374 | 309 | 402 | 400 | 446 | 365 | 465 | 436 |
| Tax % | 25% | 23% | 21% | 23% | -10% | 17% | 26% | 26% |
| Net profit | 282 | 239 | 319 | 308 | 491 | 301 | 342 | 323 |
| EPS (₹) | 2.90 | 2.46 | 3.28 | 3.17 | 5.05 | 3.09 | 3.52 | 3.32 |
Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.
Max Healthcare Institute Ltd annual results
| ₹ crore | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,608 | 1,729 | 1,691 | 1,059 | 2,508 | 3,937 | 4,563 | 5,406 | 7,028 | 8,373 | 8,712 |
| Operating profit | 141 | 113 | 156 | 94 | 407 | 951 | 1,241 | 1,493 | 1,849 | 2,243 | 2,318 |
| OPM % | 9% | 7% | 9% | 9% | 16% | 24% | 27% | 28% | 26% | 27% | 27% |
| Net profit | 16 | -25 | -0 | 59 | -138 | 605 | 1,104 | 1,058 | 1,076 | 1,442 | 1,457 |
| EPS (₹) | 0.29 | -0.47 | -0.06 | 1.10 | -1.42 | 6.24 | 11.37 | 10.88 | 11.07 | 14.82 | 14.98 |
TTM is the trailing twelve months to the most recent quarter.
Max Healthcare Institute Ltd balance sheet
| ₹ crore | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Equity capital | 537 | 537 | 537 | 537 | 966 | 970 | 971 | 972 | 972 | 973 |
| Reserves | 655 | 627 | 426 | 2,016 | 4,673 | 5,313 | 6,439 | 7,436 | 8,409 | 9,774 |
| Borrowings | 874 | 981 | 1,003 | 875 | 1,101 | 913 | 689 | 1,299 | 3,010 | 3,478 |
| Other liabilities | 1,080 | 1,157 | 1,389 | 546 | 1,803 | 1,993 | 2,003 | 2,293 | 2,795 | 2,959 |
| Total liabilities | 3,146 | 3,302 | 3,355 | 3,974 | 8,543 | 9,189 | 10,102 | 12,000 | 15,186 | 17,184 |
| Fixed assets | 2,244 | 2,227 | 2,192 | 851 | 6,536 | 7,018 | 7,039 | 8,784 | 11,502 | 12,991 |
| CWIP | 46 | 38 | 87 | 28 | 27 | 151 | 252 | 553 | 901 | 593 |
| Investments | 0 | 0 | 1 | 2,182 | 1 | 1 | 1 | 2 | 3 | 5 |
| Other assets | 856 | 1,036 | 1,075 | 913 | 1,980 | 2,020 | 2,810 | 2,661 | 2,781 | 3,595 |
| Total assets | 3,146 | 3,302 | 3,355 | 3,974 | 8,543 | 9,189 | 10,102 | 12,000 | 15,186 | 17,184 |
As reported by the company. Total assets equal total liabilities by construction.
Max Healthcare Institute Ltd cash flow
| ₹ crore | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | 156 | 166 | 89 | 77 | 118 | 741 | 1,209 | 1,122 | 1,438 | 1,633 |
| Cash from investing | -104 | -124 | -17 | -2,641 | 206 | -764 | -1,187 | -1,253 | -1,593 | -1,688 |
| Cash from financing | -48 | -48 | -74 | 2,353 | 191 | -294 | -289 | -264 | -163 | 59 |
| Net cash flow | 4 | -6 | -2 | -210 | 516 | -317 | -266 | -395 | -318 | 4 |
| Free cash flow | 41 | 100 | -27 | -13 | 1 | 192 | 877 | 342 | 500 | 165 |
| CFO / operating profit | 135% | 166% | 75% | 89% | 15% | 89% | 110% | 93% | 95% | 89% |
Negative figures are outflows. CFO / operating profit is a ratio, not an amount.
Max Healthcare Institute Ltd operating ratios
| Per year | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| ROCE % | — | 4% | 6% | 4% | 7% | 12% | 15% | 16% | 15% | 15% |
| Debtor days | 53 | 59 | 78 | 33 | 53 | 36 | 27 | 31 | 36 | 42 |
| Inventory days | 20 | 24 | 26 | 43 | 34 | 24 | 30 | 26 | 26 | 23 |
| Days payable | 184 | 227 | 292 | 286 | 274 | 174 | 212 | 207 | 198 | 175 |
| Cash conversion cycle | -111 | -144 | -188 | -210 | -187 | -114 | -155 | -149 | -136 | -110 |
| Working capital days | -12 | -24 | -152 | -137 | -44 | -24 | -46 | -43 | -46 | -41 |
Ratios as computed by the source from the reported statements. Rows a company does not report are omitted.
Max Healthcare Institute Ltd shareholding pattern
Promoters held 23.71% at Jun 2026, broadly unchanged since Jun 2025. FIIs 41.78% and DIIs 29.95%.
| % held | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 23.74% | 23.74% | 23.74% | 23.74% | 23.74% | 23.72% | 23.71% | 23.71% |
| FIIs | 57.29% | 56.93% | 54.74% | 54.76% | 51.80% | 50.55% | 45.39% | 41.78% |
| DIIs | 15.14% | 15.55% | 17.59% | 17.41% | 20.03% | 21.20% | 26.32% | 29.95% |
| Public | 3.84% | 3.77% | 3.94% | 4.09% | 4.43% | 4.52% | 4.58% | 4.55% |
| No. of shareholders | 1,37,856 | 1,40,028 | 1,51,633 | 1,62,119 | 1,80,891 | 2,03,837 | 2,16,996 | 2,24,606 |
As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.
Upcoming Max Healthcare Institute Ltd events
The next scheduled event is a corporate event on 22 Oct 2026.
- Corporate eventPostal ballot for approval of PRSU Scheme 2026, remuneration of CMD, and alteration of Main Objects Clause
- EGMPostal ballot for RSU scheme, remuneration of MD, and alteration of MOA
See the full results calendar for every Indian company reporting in the next 30 days.
Max Healthcare Institute Ltd corporate filings
- Max Healthcare receives reaffirmation of credit ratings from CARE Ratings, with long-term facilities upgraded to INR 1,818.88 crore and short-term facilities maintained at INR 80 croreCompany Updatehigh impact
Cruxal's analysis: Max Healthcare Institute Limited has secured a positive credit rating reaffirmation from…
Read the full analysis - Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018Company Updatelow impact
- Max Healthcare Discloses Regulatory Filing; No Financial Impact ReportedCompany Updatelow impact
Cruxal's analysis: Max Healthcare Institute Ltd filed a disclosure under Regulation 30 of SEBI (Listing…
Read the full analysis - Closure of Trading WindowInsider Trading / SASTlow impact
- Max Healthcare Institute Ltd announces newspaper publication of Postal Ballot NoticeCompany Updatelow impact
Cruxal's analysis: Max Healthcare Institute Ltd has published a notice in newspapers regarding a Postal…
Read the full analysis - Max Healthcare Announces Postal Ballot for New Performance-Linked RSU Scheme and Remuneration Approval for CMDAGM/EGMmedium impact
Cruxal's analysis: Max Healthcare Institute Limited has issued a postal ballot notice seeking shareholder…
Read the full analysis - Max Healthcare Institute Ltd: Routine Regulatory Disclosure under Regulation 30Company Updatelow impact
Cruxal's analysis: Max Healthcare Institute Ltd has filed a routine disclosure under Regulation 30 of the…
Read the full analysis - Max Healthcare Institute Ltd announces schedule for investor conferenceCompany Updatelow impact
Cruxal's analysis: Max Healthcare Institute Ltd has issued an intimation regarding a scheduled investor…
Read the full analysis - Max Healthcare Institute Ltd schedules investor conferenceCompany Updatelow impact
Cruxal's analysis: Max Healthcare Institute Ltd has announced a schedule for an upcoming investor…
Read the full analysis - Max Healthcare Institute Ltd: Routine Regulatory Disclosure under SEBI Regulation 30Company Updatelow impact
Cruxal's analysis: Max Healthcare Institute Ltd has filed a routine disclosure under Regulation 30 of the…
Read the full analysis - Max Healthcare Institute Ltd announces newspaper publication for shifting of registered officeCompany Updatelow impact
Cruxal's analysis: Max Healthcare Institute Ltd has published a notice in newspapers regarding the shifting…
Read the full analysis - Max Healthcare increases stake in subsidiary Kalinga Hospital Ltd to 66.15% via 87.87 crore capital infusionCompany Updatelow impact
Cruxal's analysis: Max Healthcare Institute Limited has completed the infusion of 87.87 crore into its…
Read the full analysis - Max Healthcare Institute Ltd announces allotment of equity shares under ESOP 2022Company Updatelow impact
Cruxal's analysis: Max Healthcare Institute Ltd has completed the allotment of equity shares pursuant to the…
Read the full analysis - Max Healthcare to infuse 87.87 crore into subsidiary Kalinga Hospital Ltd. for capex and modernizationCompany Updatelow impact
Cruxal's analysis: Max Healthcare Institute Limited has announced an additional capital infusion of 87.87…
Read the full analysis - Max Healthcare inaugurates 400-bed tower at Max Smart Super Speciality Hospital, SaketCompany Updatemedium impact
Cruxal's analysis: Max Healthcare Institute Ltd has expanded its capacity with the inauguration of a new…
Read the full analysis - Max Healthcare Institute Ltd: Routine Regulatory Disclosure under SEBI Regulation 30Company Updatelow impact
Cruxal's analysis: Max Healthcare Institute Ltd has filed a routine disclosure under Regulation 30 of the…
Read the full analysis - Max Healthcare Q1 FY27 Earnings Call Transcript: Focus on Capacity Expansion and Medical Education PivotCompany Updatehigh impact
Cruxal's analysis: Max Healthcare Institute Limited reported Q1 FY27 revenue growth of 16% YoY and operating…
Read the full analysis - Max Healthcare Institute Ltd files routine regulatory disclosure under SEBI Regulation 30Company Updatelow impact
Cruxal's analysis: Max Healthcare Institute Ltd has submitted a routine disclosure under Regulation 30 of…
Read the full analysis - Max Healthcare Investor Presentation Highlights Strong Q1 FY27 Performance and Robust Expansion PipelineCompany Updatehigh impact
Cruxal's analysis: Max Healthcare Institute Limited reported a strong Q1 FY27, with net revenue of 2,835…
Read the full analysis - Max Healthcare Institute Limited announces publication of financial results for the quarter ended June 30, 2026Company Updatelow impact
Cruxal's analysis: Max Healthcare Institute Limited has formally notified the stock exchanges regarding the…
Read the full analysis
This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.
Cruxal publishes market data and coverage for information only. Nothing here is investment advice.